Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian (South&CentralAsia)
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian (South&CentralAsia)
People in the UK : have you been shocked at food prices in the supermarket ?
14/10/2025
Tell us : have ticket prices affected your love of live music ?
14/10/2025
You don’t think it will happen to you – documentary
1er/10/2025
Sign up for the Filter UK newsletter : our free weekly buying advice
10/10/2024
Sign up for the First Edition newsletter : our free daily news email
20/09/2022
Sign up for the Feast newsletter : our free Guardian food email
9/07/2019